Line Bouchard

429 total citations
8 papers, 361 citations indexed

About

Line Bouchard is a scholar working on Molecular Biology, Pharmacology and Endocrine and Autonomic Systems. According to data from OpenAlex, Line Bouchard has authored 8 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pharmacology and 2 papers in Endocrine and Autonomic Systems. Recurrent topics in Line Bouchard's work include Cannabis and Cannabinoid Research (2 papers), Neuroscience of respiration and sleep (2 papers) and Adenosine and Purinergic Signaling (1 paper). Line Bouchard is often cited by papers focused on Cannabis and Cannabinoid Research (2 papers), Neuroscience of respiration and sleep (2 papers) and Adenosine and Purinergic Signaling (1 paper). Line Bouchard collaborates with scholars based in Canada, Australia and United States. Line Bouchard's co-authors include Cynthia Laflamme, Marc Pouliot, Paul H. Naccache, Patrice E. Poubelle, Nicolas Flamand, Shaun R. McColl, André Castonguay, Pierre Nicole, André Lussier and Rinaldo de Médicis and has published in prestigious journals such as The Journal of Immunology, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Line Bouchard

8 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Line Bouchard Canada 8 123 109 81 65 39 8 361
Luling He China 10 176 1.4× 21 0.2× 86 1.1× 37 0.6× 25 0.6× 17 357
Yuanyuan Tu China 14 251 2.0× 24 0.2× 66 0.8× 17 0.3× 9 0.2× 23 511
Shukai Sun China 9 225 1.8× 36 0.3× 48 0.6× 23 0.4× 8 0.2× 17 437
Jiefang Chen China 8 142 1.2× 24 0.2× 79 1.0× 11 0.2× 16 0.4× 12 337
Tokiko Suzuki Japan 12 227 1.8× 10 0.1× 99 1.2× 106 1.6× 10 0.3× 20 486
Sherwin Xie Singapore 7 200 1.6× 87 0.8× 25 0.3× 23 0.4× 6 0.2× 8 525
Akinori Eiyama Japan 7 391 3.2× 29 0.3× 27 0.3× 28 0.4× 8 0.2× 8 651
Kevin Vivot France 14 279 2.3× 57 0.5× 48 0.6× 28 0.4× 48 1.2× 19 625
Jie Shi China 11 168 1.4× 47 0.4× 21 0.3× 13 0.2× 14 0.4× 27 415
Tohru Ishizuka Japan 8 247 2.0× 37 0.3× 29 0.4× 16 0.2× 13 0.3× 11 363

Countries citing papers authored by Line Bouchard

Since Specialization
Citations

This map shows the geographic impact of Line Bouchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Line Bouchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Line Bouchard more than expected).

Fields of papers citing papers by Line Bouchard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Line Bouchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Line Bouchard. The network helps show where Line Bouchard may publish in the future.

Co-authorship network of co-authors of Line Bouchard

This figure shows the co-authorship network connecting the top 25 collaborators of Line Bouchard. A scholar is included among the top collaborators of Line Bouchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Line Bouchard. Line Bouchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Chouinard, François, Caroline Turcotte, Marie-Chantal Larose, et al.. (2012). 2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors againstE. coli, S. aureus, HSV-1, and RSV. Journal of Leukocyte Biology. 93(2). 267–276. 40 indexed citations
2.
Legault, Jean, Isabelle Côté, Line Bouchard, et al.. (2011). Low-Concentration Methylene Blue Maintains Energy Production and Strongly Improves Survival of Leigh Syndrome French Canadian Skin Fibroblasts. Journal of Pharmacy & Pharmaceutical Sciences. 14(3). 438–438. 7 indexed citations
3.
Chouinard, François, Julie Lefebvre, Line Bouchard, et al.. (2011). The Endocannabinoid 2-Arachidonoyl-Glycerol Activates Human Neutrophils: Critical Role of Its Hydrolysis and De Novo Leukotriene B4 Biosynthesis. The Journal of Immunology. 186(5). 3188–3196. 53 indexed citations
4.
Flamand, Nicolas, Jordane Biarc, Serge Picard, et al.. (2007). Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1771(9). 1235–1245. 52 indexed citations
5.
McColl, Shaun R., et al.. (2005). Immunomodulatory impact of the A 2A adenosine receptor on the profile of chemokines produced by neutrophils. The FASEB Journal. 20(1). 187–189. 94 indexed citations
6.
Bouchard, Line, Rinaldo de Médicis, André Lussier, Paul H. Naccache, & Patrice E. Poubelle. (2002). Inflammatory Microcrystals Alter the Functional Phenotype of Human Osteoblast-Like Cells In Vitro: Synergism with IL-1 to Overexpress Cyclooxygenase-2. The Journal of Immunology. 168(10). 5310–5317. 58 indexed citations
7.
Bouchard, Line, Paul H. Naccache, & Patrice E. Poubelle. (2002). Promotion of neutrophil adherence to human osteoblasts by microcrystals and f-Met–Leu–Phe. Biochemical and Biophysical Research Communications. 296(3). 759–764. 7 indexed citations
8.
Bouchard, Line, et al.. (1992). Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)1-(3-pyridyl)-1-butanone in A/J mouse lung. Carcinogenesis. 13(3). 341–348. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026